Subscription Required

Only paid subscribers* to Drug Benefit News can access this Web portal with three years of back issues, searchable article archives and other valuable resources.

Subscribers to Drug Benefit News receive

  • 24 biweekly issues of timely news and insightful strategies for reducing costs and improving outcomes, delivered by First Class U.S. Mail and electronically,
  • E-News Alerts whenever important news breaks, and
  • Access to a subscriber-only Web page with:
    • Searchable archives of past articles,
    • Convenient library with PDFs of back issues,
    • Recent stories of interest and hot topic articles grouped for convenient reading, and
    • Regular postings from your editor.
View a sample and get more information
July 24, 2015

Recent Stories of Interest

From Drug Benefit News - Pharmaceutical manufacturers, covered entities and other stakeholders in the 340B Drug Pricing Program are once again sweating it out as an expected “mega-guidance” spends its third month at the Office of Management and Budget (OMB). Industry insiders say the pending guidance could, among other things, finally place some limits on the wildly expanding contract pharmacy arrangements that may lead to duplicate discounts being paid by manufacturers to 340B entities and commercial and/or Medicaid plans. Read more

A recent report from AdverseEvents, Inc. highlighting the downstream medical costs associated… Read more

Adding to the already frenzied pace of PBM consolidation over the last… Read more

Novartis is in talks with health care purchasers about using performance-based pricing… Read more

From the Editor

Welcome to your Drug Benefit News subscriber-only Web page

Be sure to visit often, for PDFs of issues, archives of articles and data, and more!

Please e-mail me with comments on the last issue of Drug Benefit News, story ideas for future issues or any other suggestions you have that can make the newsletter more useful for you.

August 4, 2015
CVS Performs Well in 2Q; Slashes Formulary

CVS Health posts strong 2Q 2015 earnings; cuts 26 drugs from 2016 standard formulary. http://investors.cvshealth.com

July 31, 2015
Express Scripts Formulary Excludes 80 Drugs

Express Scripts posted its 2016 National Preferred Formulary, which leaves out 80 medications. http://tinyurl.com/nrq9x48

July 29, 2015
Express Scripts Beats Street in 2Q Earnings

Express Scripts posted better-than-expected EPS for 2Q 2015 and raised the low end of retention rate for 2016. http://tinyurl.com/p7r4c7f

Updated Regularly

Featured Hot Topics

Search for your own Hot Topics

It's quick and easy to sign up for FREE access to AISHealth.com!

Why do I need to register?